CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 971 - 980 of 1143
Study Number Lead Group Study Title CIRB Study Status
A151804 Alliance Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events Adult CIRB - Late Phase Emphasis Available to Open
E2905 ECOG Randomized Phase III Trial Comparing the Frequency of Major Erythroid Response (MER) to Treatment with Lenalidomide (Revlimid) Alone and in Combination with Epoetin Alfa (Procrit) in Subjects with Low- or Intermediate-1 Risk MDS and Symptomatic Anemia Adult CIRB - Late Phase Emphasis Available to Open
A011401 Alliance Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer Adult CIRB - Late Phase Emphasis Available to Open
RTOG-0848 RTOG A Phase II-R and A Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma <br> Adult CIRB - Late Phase Emphasis Available to Open
NRG-GU013 NRG The Phase III "High Five Trial" Five Fraction Radiation for High-Risk Prostate Cancer Adult CIRB - Late Phase Emphasis Available to Open
AMC-107 AMC A Phase 2 Trial of Ixazomib for Kaposi Sarcoma Adult CIRB - Late Phase Emphasis Available to Open
N107C NCCTG A Phase III Trial of Post-Surgical Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease Adult CIRB - Late Phase Emphasis Available to Open
E1900 ECOG A Phase III Trial in Adult Acute Myeloid Leukemia: Daunorubicin Dose-<br>Intensification Prior to Risk-Allocated Autologous Stem Cell Transplantation Adult CIRB - Late Phase Emphasis Available to Open
EA5123 ECOG-ACRIN Role of Early 18F-FDG-PET/CT Scan in Predicting Mediastinal Downstaging with Neoadjuvant Chemotherapy in Resectable Stage III A NSCLC Adult CIRB - Late Phase Emphasis Completed
NRG-GU012 NRG Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Unresected Renal Cell Carcinoma (RCC) Receiving Immunotherapy (SAMURAI) Adult CIRB - Late Phase Emphasis Available to Open
Displaying 971 - 980 of 1143